You just read:

Mallinckrodt Enrolls First Patient In Phase 4 Registry Of INOMAX® (Nitric Oxide) Gas For Inhalation For Pulmonary Hypertension In Neonates

News provided by

Mallinckrodt Pharmaceuticals

Aug 01, 2017, 07:45 ET